Health
ProAgio drug shows success against solid tumours in mice – Drug Target Review
Studies in mice have shown that the drug ProAgio is effective at treating pancreatic cancer and triple-negative breast cancer.
Posted: 10 February 2021 | Victoria Rees (Drug Target Review) | No comments yet
Studies in mice have shown that the drug ProAgio is effective at treating pancreatic cancer and triple-negative breast cancer.
A new drug named ProAgio has demonstrated efficacy at treating pancreatic cancer and prolonging survival in mice, according to a study. A second study also shows that the drug is effective against triple-negative breast cancer. The drug was developed by Georgia State University, US, Professor…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News15 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News23 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo
-
General20 hours agoTrump’s AUKUS review coming soon. Will he stop the folly?